developed an induced pluripotent stem cell (iPSC) model using samples from three patients with MMD and three healthy controls and revealed that iPSCs obtained from individuals who are heterozygous or homozygous for RNF213 R4810K exhibit markedly reduced angiogenic activity. The gene discussed is RNF213; the disease is multiminicore myopathy.